What is he best known for?
The fields of study he is best known for:
Reinhard Ebner mostly deals with Cell biology, Molecular biology, Biochemistry, Computational biology and Recombinant DNA.
His Cell biology research is multidisciplinary, incorporating perspectives in Receptor and Interleukin 1 receptor, type I.
Reinhard Ebner interconnects Decoy receptor 3, Lymphotoxin beta receptor and Peptide sequence in the investigation of issues within Molecular biology.
His work focuses on many connections between Computational biology and other disciplines, such as Drug development, that overlap with his field of interest in Cell survival, Human tumor, Carcinoma Cell and Multicellular spheroid.
His Recombinant DNA research includes themes of Human proteins, Nucleic acid, Polynucleotide and Antibody, Immunology.
His work carried out in the field of Nucleic acid brings together such families of science as Secretory protein, Immune system, Alternative splicing and Coding region.
His most cited work include:
- The Receptor for the Cytotoxic Ligand TRAIL (1607 citations)
- Spheroid-based drug screen: considerations and practical approach (957 citations)
- TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. (795 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Recombinant DNA, Nucleic acid, Cell biology, Antibody and Molecular biology.
The various areas that he examines in his Recombinant DNA study include Tumor necrosis factor alpha, Polynucleotide, Cancer research and Computational biology.
The Nucleic acid study combines topics in areas such as Host and Immune system.
Reinhard Ebner has researched Cell biology in several fields, including SUPERFAMILY, Secretory protein and Cell growth.
The Molecular biology study which covers Receptor that intersects with Beta.
His PEP group translocation study, which is part of a larger body of work in Biochemistry, is frequently linked to Sucrose transport, bridging the gap between disciplines.
He most often published in these fields:
- Recombinant DNA (45.29%)
- Nucleic acid (44.12%)
- Cell biology (35.29%)
What were the highlights of his more recent work (between 2005-2018)?
- Nucleic acid (44.12%)
- Recombinant DNA (45.29%)
- Cancer research (15.29%)
In recent papers he was focusing on the following fields of study:
Reinhard Ebner mainly investigates Nucleic acid, Recombinant DNA, Cancer research, Molecular biology and Diagnostic methods.
His Nucleic acid research is multidisciplinary, relying on both Growth factor and Immune system.
His Immune system study combines topics in areas such as Tumor necrosis factor alpha and Antibody.
His Cancer research research is multidisciplinary, relying on both Cancer, Colorectal cancer, Chemoradiotherapy and Suspension culture.
His Molecular biology research integrates issues from Spheroid and Irinotecan.
The study incorporates disciplines such as Pathology and Cell biology in addition to SUPERFAMILY.
Between 2005 and 2018, his most popular works were:
- Spheroid-based drug screen: considerations and practical approach (957 citations)
- Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge? (332 citations)
- Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy (168 citations)
In his most recent research, the most cited papers focused on:
His main research concerns Cancer research, Chemoradiotherapy, Computational biology, Spheroid and Colorectal cancer.
His Cancer research research includes elements of Tumor Pathology, Suspension culture, Anticancer drug and Cellular pathology.
His study looks at the relationship between Chemoradiotherapy and topics such as STAT3, which overlap with In vivo, Western blot, Cancer and Mediator.
The various areas that Reinhard Ebner examines in his Computational biology study include Cell survival, Gene regulatory network and Gene expression profiling.
The Spheroid study combines topics in areas such as Acid phosphatase, Tumor tissue, Drug development and Flow cytometry.
His Drug development research is multidisciplinary, incorporating elements of Human tumor, Multicellular spheroid, Drug treatment and Carcinoma Cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
